Inspire Medical Systems Inc (INSP) - Total Liabilities
Based on the latest financial reports, Inspire Medical Systems Inc (INSP) has total liabilities worth $119.04 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Inspire Medical Systems Inc - Total Liabilities Trend (2016–2025)
This chart illustrates how Inspire Medical Systems Inc's total liabilities have evolved over time, based on quarterly financial data. See Inspire Medical Systems Inc (INSP) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Inspire Medical Systems Inc Competitors by Total Liabilities
The table below lists competitors of Inspire Medical Systems Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Huludao Zinc Industry Co Ltd
SHE:000751
|
China | CN¥7.34 Billion |
|
First Tractor Co Ltd
SHG:601038
|
China | CN¥6.66 Billion |
|
Ouster, Inc. Common Stock
NASDAQ:OUST
|
USA | $87.78 Million |
|
Jiangxi Hungpai New Material Co Ltd
SHG:605366
|
China | CN¥1.15 Billion |
|
Frontier Group Holdings Inc
NASDAQ:ULCC
|
USA | $6.79 Billion |
|
Shenzhen Baoming Technology Co
SHE:002992
|
China | CN¥1.38 Billion |
|
Gold.com, Inc.
NYSE:GOLD
|
USA | $3.27 Billion |
|
tonies SE
F:TNIE
|
Germany | €169.98 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Inspire Medical Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Inspire Medical Systems Inc worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inspire Medical Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inspire Medical Systems Inc (2016–2025)
The table below shows the annual total liabilities of Inspire Medical Systems Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $126.16 Million | +6.29% |
| 2024-12-31 | $118.69 Million | +13.80% |
| 2023-12-31 | $104.30 Million | +51.44% |
| 2022-12-31 | $68.87 Million | +4.29% |
| 2021-12-31 | $66.04 Million | +28.37% |
| 2020-12-31 | $51.44 Million | +24.20% |
| 2019-12-31 | $41.42 Million | +14.79% |
| 2018-12-31 | $36.08 Million | +52.84% |
| 2017-12-31 | $23.61 Million | +19.69% |
| 2016-12-31 | $19.72 Million | -- |
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more